Skip to content
10-Q

Quarterly Report

Orion Biotech Opportunities Corp.

0001213900-22-070727

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$371.45K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $341.03K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $712.47K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$7.39M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$7.41M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$9.14M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$13.76M
Current Liabilities Q3 2022 · Sep 30, 2022 $57.97K
Current Liabilities Q3 2022 · Dec 31, 2021 $81.63K
Total Liabilities Q3 2022 · Sep 30, 2022 $8.12M
Total Liabilities Q3 2022 · Dec 31, 2021 $15.12M
Current Assets Q3 2022 · Sep 30, 2022 $633.22K
Current Assets Q3 2022 · Dec 31, 2021 $1.35M
Total Assets Q3 2022 · Sep 30, 2022 $201.83M
Total Assets Q3 2022 · Dec 31, 2021 $201.36M
Sga Expense Q3 2022 · Sep 30, 2022 $175.46K
Sga Expense Q3 2022 · Sep 30, 2022 $606.15K
Sga Expense Q3 2022 · Jun 30, 2021 $378.66K
Net Income Q3 2022 · Sep 30, 2022 $920.26K
Net Income Q3 2022 · Sep 30, 2022 $7.47M
Net Income Q3 2022 · Jun 30, 2022 $1.93M
Net Income Q3 2022 · Mar 31, 2022 $4.62M
Net Income Q3 2022 · Jun 30, 2021 −$2.05M
Net Income Q3 2022 · Jun 30, 2021 $171.16K
Net Income Q3 2022 · Mar 31, 2021 −$45.09K
Operating Income Q3 2022 · Sep 30, 2022 −$205.46K
Operating Income Q3 2022 · Sep 30, 2022 −$696.15K
Operating Income Q3 2022 · Jun 30, 2021 −$423.18K